Author:
Abubakar Mustapha,Orr Nick,Daley Frances,Coulson Penny,Ali H. Raza,Blows Fiona,Benitez Javier,Milne Roger,Brenner Herman,Stegmaier Christa,Mannermaa Arto,Chang-Claude Jenny,Rudolph Anja,Sinn Peter,Couch Fergus J.,Devilee Peter,Tollenaar Rob A. E. M.,Seynaeve Caroline,Figueroa Jonine,Sherman Mark E.,Lissowska Jolanta,Hewitt Stephen,Eccles Diana,Hooning Maartje J.,Hollestelle Antoinette,Martens John W. M.,van Deurzen Carolien H. M.,Investigators kConFab,Bolla Manjeet K.,Wang Qin,Jones Michael,Schoemaker Minouk,Wesseling Jelle,van Leeuwen Flora E.,Van ‘t Veer Laura,Easton Douglas,Swerdlow Anthony J.,Dowsett Mitch,Pharoah Paul D.,Schmidt Marjanka K.,Garcia-Closas Montserrat
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thürlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2015;12:296–301. doi:10.1038/nrclinonc.2015.46.
2. Senkus E, Kyriakides S, Penault-Llorca F, Poortmans P, Thompson A, Zackrisson S, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;22:2013.
3. Andre F, Arnedos M, Goubar A, Ghouadni A, Delaloge S. Ki67—no evidence for its use in node-positive breast cancer. Nat Rev Clin Oncol. 2015;12:296–301. doi:10.1038/nrclinonc.2015.46.
4. Urruticoechea A, Smith IE, Dowsett M. Proliferation marker Ki-67 in early breast cancer. J Clin Oncol. 2005;23(28):7212–20.
5. Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA. Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol. 2010;11(2):174–83.